Effects of bone morphogenetic protein-2 and transforming growth factor β1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells

Journal of Molecular Histology

Volumn 35, Issue 1, 2004, Pages 81-90

  Takagi, Minoru ^a   Kamiya, Naoko ^a   Takahashi, Tomihisa ^a   Ito, Shinsuke ^a   Hasegawa, Mitsuharu ^a   Suzuki, Naoto ^a   Nakanishi, Koji ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; SIALOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AJ18; TRANSCRIPTION FACTOR DLX5; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BMP2 PROTEIN, RAT; BONE MORPHOGENETIC PROTEIN; DNA BINDING PROTEIN; REPRESSOR PROTEIN; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN; ZNF354C PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; NONHUMAN; NORTHERN BLOTTING; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; ANIMAL; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; UPREGULATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; DNA-BINDING PROTEINS; GENE EXPRESSION; NEOPLASM PROTEINS; OSTEOBLASTS; RATS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 16544363883     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:HIJO.0000021151.31118.e3     Document Type: Article

References (74)

1. Ahrens M, Ankenbauer T, Schroder D, Hollnagel A, Mayer H, Gross G (1993) Expression of human bone morphogenetic proteins-2 or -4 in murine mesenchymal progenitor C3H10T1/2 cells induces differentiation into distinct mesenchymal cell lineages. DNA Cell Biol 12: 871-880.
2. Aubin JE (1999) Osteoprogenitor cell frequency in rat bone marrow stromal populations: Role for heterotypic cell-cell interactions in osteoblast differentiation. J Cell Biochem 72: 396-410.
3. Bae SC, Lee KS, Zhang YW, Ito Y (2001) Intimate relationship between TGF-beta/BMP signaling and runt domain transcription factor, PEBP2/CBF. J Bone Joint Surg Am 83-A Suppl 1(Pt 1): S48-S55.
4. Baker JC, Harland RM (1997) From receptor to nucleus: The Smad pathway. Curr Opin Genet Dev 7: 467-473.
5. Barnes GL, Javed A, Waller SM, Kamal MH, Hebert KE, Hassan MQ, Bellahcene A, Van Wijnen AJ, Young MF, Lian JB, Stein GS, Gerstenfeld LC (2003) Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63: 2631-2637.
6. Boström K, Tsao D, Shen S, Wang Y, Demer LL (2001) Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276: 14044-14052.
7. Bunyaratavej P, Hullinger TG, Somerman MJ (2000) Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells. Exp Cell Res 260: 324-333.
8. Byers BA, Pavlath GK, Murphy TJ, Karsenty G, Garcia AJ (2002) Cell-type-dependent up-regulation of in vitro mineralization after overexpression of the osteoblast-specific transcription factor Runx2/Cbfa1. J Bone Miner Res 17: 1931-1944.
9. Chen J, Zhang Q, McCulloch CA, Sodek J (1991) Immunohistochemical localization of bone sialoprotein in foetal porcine bone tissues: Comparisons with secreted phosphoprotein 1 (SPP-1, osteopontin) and SPARC (osteonectin). Histochem J 23: 281-289.
10. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR, Harris SE (1998) Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. J Cell Biol 142: 295-305.
11. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA (2003) Msx2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278: 45969-45977.
12. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
13. Dodig M, Tadic T, Kronenberg MS, Dacic S, Liu YH, Maxson R, Rowe DW, Lichtler AC (1999) Ectopic Msx2 overexpression inhibits and Msx2 antisense stimulates calvarial osteoblast differentiation. Dev Biol 209: 298-307.
14. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G ( 1997) Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89: 747-754.
15. Ebisawa T, Tada K, Kitajima I, Tojo K, Sampath TK, Kawabata M, Miyazono K, Imamura T (1999) Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J Cell Sci 112: 3519-3527.
16. Ganss B, Kim RH, Sodek J (1999) Bone sialoprotein. Crit Rev Oral Bio Med 10: 79-98.
17. Gazit D, Ebner R, Kahn AJ, Derynck R (1993) Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol 7: 189-198.
18. Geoffroy V, Ducy P, Karsenty G (1995) A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 270: 30973-30979.
19. Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P (2002) High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Mol Cell Biol 22: 6222-6233.
20. Gibson UE, Heid CA, Williams PM (1996) A novel method for real time quantitative RT-PCR. Genome Res 6: 995-1001.
21. Gitelman SE, Kirk M, Ye J-Q, Filvaroff EH, Kahn AJ, Derynck R (1995) Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells. Cell Growth Differ 6: 827-836.
22. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL (1999) Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14: 1522-1535.
23. Harada H, Tagashira S, Fujiwara M, Ogawa S, Katsumata T, Yamaguchi A, Komori T, Nakatsuka M (1999) Cbfa1 isoforms exert functional differences in osteoblast differentiation. J Biol Chem 274: 6972-6978.
24. Hunter GK, Goldberg HA (1993) Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 90: 8562-8565.
25. Jabs EW, Muller U, Li X, Ma L, Luo W, Haworth IS, Klisak I, Sparkes R, Warman ML, Mulliken JB, Snead ML, Maxson R (1993) A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75: 443-450.
26. Javed A, Barnes GL, Jasanya BO, Stein JL, Gerstenfeld L, Lian JB, Stein GS (2001) runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol 21: 2891-2905.
27. Jheon AH, Ganss B, Cheifetz S, Sodek J (2001) Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development. J Biol Chem 276: 18282-18289.
28. Katagiri T, Takahashi N (2002) Regulatory mechanisms of osteoblast and osteoclast differentiation. Oral Dis 8: 147-159.
29. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T (1990) The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 172: 295-299.
30. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127: 1755-1766.
31. Kawabata M, Imamura T, Miyazono K (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9: 49-61.
32. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
33. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB, Ryoo HM (1999) Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 73: 114-125.
34. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792.
35. Li IW, Cheifetz S, McCulloch CA, Sampath KT, Sodek J (1996) Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvarial cells are differentiation stage specific. J Cell Physiol 169: 115-125.
36. Liu YH, Kundu R, Wu L, Luo W, Ignelzi MAJ, Snead ML, Maxson REJ (1995) Premature suture closure and ectopic cranial bone in mice expressing Msx2 transgenes in the developing skull. Proc Natl Acad Sci USA 92: 6137-6141.
37. Liu YH, Tang Z, Kundu RK, Wu L, Luo W, Zhu D, Sangiorgi F, Snead ML, Maxson RE (1999) Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: A possible mechanism for MSX2-mediated graniosynostosis in humans. Dev Biol 205: 260-274.
38. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A, Komori T (2001) Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 155: 157-166.
39. Maliakal JC, Asahina I, Hauschka PV, Sampath TK (1994) Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors 11: 227-234.
40. McKee MD, Nanci A, Khan SR (1995) Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. Bone Miner Res 10: 1913-1929.
41. Mina M, Gluhak J, Upholt WB, Kollar EJ, Rogers B (1995) Experimental analysis of Msx-1 and Msx-2 gene expression during chick mandibular morphogenesis. Dev Dynam 202: 195-214.
42. Miyama K, Yamada G, Yamamoto TS, Takagi C, Miyado K, Sakai M, Ueno N, Shibuya H (1999) A BMP-inducible gene, dlx5, regulates osteoblast differentiation and mesoderm induction. Dev Biol 208: 123-133.
43. Nakase T, Takaoka K, Masuhara K, Shimizu K, Yoshikawa H, Ochi T (1997) Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 21: 17-21.
44. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
45. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR, Yoneda T (1998) Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 273: 1872-1879.
46. Nishitoh H, Ichijo H, Kimura M, Matsumoto T, Makishima F, Yamaguchi A, Yamashita H, Enomoto S, Miyazono K (1996) Identification of type I and type II serine/threonine kinase receptors for growth/differentiation factor-5. J Biol Chem 271: 21345-21352.
47. Ogata Y, Yamauchi M, Kim RH, Li JJ, Freedman LP, Sodek J (1995) Glucocorticoid regulation of bone sialoprotein (BSP) gene expression. Identification of a glucocorticoid response element in the bone sialoprotein gene promoter. Eur J Biochem 230: 183-192.
48. Oldberg Å, Franzén A, Heinegård D (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83: 8819-8823.
49. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GW, Beddington RS, Mundlos S, Olsen BR, Selby PB, Owen MJ (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89: 765-771.
50. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990) Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143: 420-430.
51. Price PA, Urist MR, Otawara Y (1983) Matrix Gla protein, a new γ-carboxyglutamic acid-containing protein which is associated with the organic matrix bone. Biochem Biophys Res Commun 117: 765-771.
52. Qiu M, Bulfone A, Martinez S, Meneses JJ, Shimamura K, Pedersen RA, Rubenstein JL (1995) Null mutation of Dlx-2 results in abnormal morphogenesis of proximal first and second branchial arch derivatives and abnormal differentiation in the forebrain. Genes Dev 9: 2523-2538.
53. Reddi AH (1997) Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev 8: 11-20.
54. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I (1994) Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161: 218-228.
55. Rosen V, Nove J, Song JJ, Thies RS, Cox K, Wozney JM (1994) Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res 9: 1759-1768.
56. Ryoo HM, Hoffmann HM, Beumer T, Frenkel B, Towler DA, Stein GS, Stein JL, van Wijnen AJ, Lian JB (1997) Stage-specific expression of Dlx-5 during osteoblast differentiation: Involvement in regulation of osteocalcin gene expression. Mol Endocrinol 11: 1681-1694.
57. Sampath TK, Maliakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RHL, Corbett C, Ozkaynak E, Oppermann H, Rueger DC (1992) Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267: 20352-20362.
58. Shanahan CM, Proudfoot D, Farzaneh-Far A, Weissberg PL (1998) The role of Gla proteins in vascular calcification. Crit Rev Eukaryot Gene Exp 8: 357-375.
59. Shirakabe K, Terasawa K, Miyama K, Shibuya H, Nishida E (2001) Regulation of the activity of the transcription factor Runx2 by two homeobox proteins, Msx2 and Dlx5. Genes Cells 6: 851-856.
60. Sumoy L, Wang CK, Lichtler AC, Pierro LJ, Kosher RA, Upholt WB (1995) Identification of a spatially specific enhancer element in the chicken Msx-2 gene that regulates its expression in the apical ectodermal ridge of the developing limb buds of transgenic mice. Dev Biol 170: 230-242.
61. Takagi M, Yamada T, Kamiya N, Kumagai T, Yamaguchi A (1999) Effects of bone morphogenetic protein-2 and transforming growth factor-β1 on gene expression of decorin and biglycan by cultured osteoblastic cells. Histochem J 31: 403-409.
62. Takuwa Y, Ohse C, Wang EA, Wozney JM, Yamashita K (1991) Bone morphogenetic protein-2 stimulates alkaline phosphatase activity and collagen synthesis in cultured osteoblastic cells, MC3T3-E1. Biochem Biophys Res Commun 174: 96-101.
63. Tamaki K, Souchelnytskyi S, Itoh S, Nakao A, Sampath K, Heldin CH, ten Dijke P (1998) Intracellular signaling of osteogenic protein-1 through Smad5 activation. J Cell Physiol 177: 355-363.
64. Urist MR (1965) Bone: Formation by autoinduction. Science 150: 893-899.
65. Wang EA, Israel DI, Kelly S, Luxenberg DP (1993) Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9: 57-71.
66. Whitman M (1998) Smads and early developmental signaling by the TGF beta superfamily. Genes Dev 12, 2445-2462.
67. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: Molecular clones and activities. Science 242: 1528-1534.
68. Yagi K, Tsuji K, Nifuji A, Shinomiya K, Nakashima K, DeCrombrugghe B, Noda M (2003) Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes. J Cell Biochem 88: 1077-1083.
69. Yamada T, Kamiya N, Harada D, Takagi M (1999) Effects of transforming growth factor-β1 in the gene expression of decorin, biglycan, and alkaline phosphatase in osteoblast precursor cells and more differentiated osteoblast cells. Histochem J 31: 687-694.
70. Yamaguchi A, Kahn AJ (1991) Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int 49: 221-225.
71. Yamaguchi A, Komori T, Suda T (2000) Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21: 393-411.
72. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113: 681-687.
73. Yang X, Karsenty G (2002) Transcription factors in bone: Developmental and pathological aspects. Trends Mol Med 8: 340-345.
74. Zebboudj AF, Imura M, Bostrom K (2002) Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 277: 4388-4394.